Studies on the involvement of sialyltransferases in thyroid cancer mainly focused on N-acetylgalactosamine-specific α2,6-sialyltransferase 2 (ST6GalNAc2) [36,37]. The gene discussed is ST6GALNAC2; the disease is thyroid gland carcinoma.